# PAVmed (PAVM) — Analyst Forecast

PAVM · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/pavm/forecast

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Aug 27, 2026 | Ascendiant Capital | Maintained | Buy | $57.00 |
| Jun 8, 2026 | Ascendiant Capital | Maintained | Buy | $56.00 |
| Apr 9, 2026 | Ascendiant Capital | Maintained | Buy | $65.00 |
| Dec 10, 2025 | Ascendiant Capital | Maintained | Buy | $17.00 |
| Oct 6, 2025 | Ascendiant Capital | Maintained | Buy | $20.00 |
| Jun 6, 2025 | Ascendiant Capital | Maintained | Buy | $19.00 |
| Apr 21, 2025 | Ascendiant Capital | Maintained | Buy | $19.50 |
| Dec 9, 2024 | Ascendiant Capital | Maintained | Buy | $19.00 |
| Aug 18, 2023 | Cantor Fitzgerald | Maintained | Neutral | $1.40 |

## Frequently Asked Questions

### What is the latest analyst rating on PAVM?

On Aug 27, 2026, Ascendiant Capital maintained PAVmed at Buy with a price target of $57.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).